LRRC15+CAF have been found to hamper the function of CD8+ T cells, and specific consumption of LRRC15+CAF using Lrrc15-diphtheria toxin receptor inhibited tumor growth and increased ICB response [294]. The gene discussed is CD8A; the disease is neoplasm.